BIOCORP: Novo Nordisk acquires all shares of drug delivery device maker Biocorp

Novo Nordisk today officially acquired 100% of the shares of Biocorp, the France-based drug delivery device maker's CEO announced. Biocorp designs, develops and manufactures drug delivery systems and medical devices. Its offerings include Mallya, a Bluetooth-enabled smart add-on device for pen injectors. The Mallya smart sensor attaches directly to insulin pen injectors to make them [...]The post Novo Nordisk acquires all shares of drug delivery device maker Biocorp appeared first on Drug Delivery Business.